87 related articles for article (PubMed ID: 6172087)
21. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
22. [In vitro reaction of lymph node cells of mice to protein and cell-bound antigens. A study with the macrophage electrophoretic mobility test ].
Schäffner H
Allerg Immunol (Leipz); 1981; 27(3):145-52. PubMed ID: 6181671
[TBL] [Abstract][Full Text] [Related]
23. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction.
Källén B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65098
[TBL] [Abstract][Full Text] [Related]
24. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.
Bourdette DN; Whitham RH; Chou YK; Morrison WJ; Atherton J; Kenny C; Liefeld D; Hashim GA; Offner H; Vandenbark AA
J Immunol; 1994 Mar; 152(5):2510-9. PubMed ID: 7510746
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic problem in multiple sclerosis (M.S.): two specific laboratory tests.
Field EJ
Boll Ist Sieroter Milan; 1978 Jan; 56(6):552-6. PubMed ID: 75734
[TBL] [Abstract][Full Text] [Related]
26. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
[TBL] [Abstract][Full Text] [Related]
27. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
28. Effect of encephalitogenic protein on migration in agarose of leukoytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction.
Källen B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65894
[TBL] [Abstract][Full Text] [Related]
29. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
30. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
Tejada-Simon MV; Zang YC; Hong J; Rivera VM; Zhang JZ
Ann Neurol; 2003 Feb; 53(2):189-97. PubMed ID: 12557285
[TBL] [Abstract][Full Text] [Related]
31. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
Muhrer KH; Schwemmle K; Filler D; Kahle M
Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
[TBL] [Abstract][Full Text] [Related]
32. Cell-mediated immunity in multiple sclerosis as determined by sensitivity of different lymphocyte populations to various brain tissue antigens.
Brinkman CJ; Nillesen WM; Hommes OR; Lamers KJ; de Pauw BE; Delmotte P
Ann Neurol; 1982 May; 11(5):450-5. PubMed ID: 6179459
[TBL] [Abstract][Full Text] [Related]
33. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
[TBL] [Abstract][Full Text] [Related]
34. Differences of the in vitro reactivity of lymphocytes from normal and persistently lymphocytotic cows to enzootic bovine leukosis tumour membrane extracts as detected with the macrophage-electrophoretic mobility test.
Ristau E; Schlott B; Gryschek G; Wittmann W
Acta Biol Med Ger; 1982; 41(7-8):705-13. PubMed ID: 7148278
[TBL] [Abstract][Full Text] [Related]
35. [Immunopathogenesis of the Vogt-Koyanagi-Harada syndrome].
Uthoff D; Müller-Ruchholtz W; Böke W
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Jun; 210(4):251-9. PubMed ID: 91325
[TBL] [Abstract][Full Text] [Related]
36. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals.
Pelfrey CM; Tranquill LR; Boehme SA; McFarland HF; Lenardo MJ
J Immunol; 1995 Jun; 154(11):6191-202. PubMed ID: 7538545
[TBL] [Abstract][Full Text] [Related]
37. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein.
Puri J; Arnon R; Gurevich E; Teitelbaum D
J Immunol; 1997 Mar; 158(5):2471-6. PubMed ID: 9036999
[TBL] [Abstract][Full Text] [Related]
39. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
40. Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.
Greer JM; Csurhes PA; Pender MP; McCombe PA
J Autoimmun; 2004 Jun; 22(4):345-52. PubMed ID: 15120759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
